Medical Writing Visual Communications Clinical trial design: Considerations for medical writers developing clinical trial protocols
front-cover

Volume 29, Issue 1 - Visual Communications

Clinical trial design: Considerations for medical writers developing clinical trial protocols

Abstract

Clinical trial protocols must provide a clear trial design to meet the study objectives. Medical writers must understand and be ready to review and discuss aspects of the trial design with the protocol development team, in order to write a clear and accurate protocol. This article reviews some of the main trial design concepts medical writers should expect to find when writing protocols.

Download the full article

References

  1. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use [Internet]. Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2). Current Step 4 version. 2016 Nov 9 [cited 2020 Jan 08]. Available from: https://database.ich.org/sites/default/files /E6_R2_Addendum.pdf.
  2. TransCelerate Biopharma Inc. Clinical Content & Reuse. 2017 [cited 2020 Jan 08]. Available from: https://transceleratebiopharmainc.com/ initiatives/clinical-content-reuse/.
  3. Chan A, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials. Ann Intern Med. 2013;158(3):200–7
  4. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use [Internet]. Structure and Content of Clinical Study Reports. Current Step 4 version. 1995 Nov 30 [cited 2020 Jan 08]. Available from: https://database.ich.org/sites/default/ files/E3_Guideline.pdf.
  5. Al-Jundi A, Sakka S. Protocol Writing in Clinical Research. J Clin Diagn Res. 2016;10(11):ZE10–3.
  6. Taylor R. Medical Writing: A Guide for Clinicians, Educators, and Researchers. 2nd ed. New York: Springer New York; 2011.
  7. Bacchieri A, Cioppa GD. Fundamentals of Clinical Research: Bridging Medicine, Statistics and Operations. Milan: Springer; 2007.
  8. Hulley SB, Cummings SR, Browner WS, Grady D, Newman TB. Designing clinical research. 4th ed. Philadelphia: Wolters Kluwer; 2013.
  9. Patino CM, Ferreira JC. Inclusion and exclusion criteria in research studies: definitions and why they matter. J Bras Pneumol. 2018;44(2):84.
  10. Spilker B. Guide to Clinical Trials. Philadelphia: Lippincott-Raven Press; 1991.
  11. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use [Internet]. Statistical Principles for Clinical Trials. E9. Current Step 4 version. 1998 Feb 5 [cited 2020 Jan 05]. Available from: https://database.ich.org/sites/default/ files/E9_Guideline.pdf.
  12. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use [Internet]. Estimands and sensitivity analysis in clinical trials. E9 (R1). Current Step 2 version. 2017 Jun 16 [cited 2020 Jan 05]. Available from: https://database.ich.org/ sites/default/files/E9-R1_ Step4_ Guideline_2019_1203.pdf.
  13. Bridge H, Schindler T. Estimands – closing the gap between study design and analysis. Med Writ. 2018;27(4):52–6.
  14. Evans SR. Clinical trial structures. J Exp Stroke Transl Med. 2010;3(1):8-18.
  15. Griffin JP, Posner J, Barker GR. The Textbook of Pharmaceutical Medicine. 7th ed Chichester: Wiley-Blackwell/BMJ Books; 2013.
  16. Suresh K. An overview of randomization techniques: An unbiased assessment of outcome in clinical research. J Hum Reprod Sci. 2011;4(1):8–11.
  17. Lim CY, In J. Randomization in clinical studies. Korean J Anesthesiol. 2019;72(3): 221–32.
  18. Brody T. Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines. Amsterdam: Academic Press; 2011.
  19. Food and Drug Administration [Internet]. Non Inferiority Clinical Trials to Establish Effectiveness – Guidance for Industry. 2016 Nov [cited 2020 Jan 05]. Available from: https://www.fda.gov/media/78504/ download.
  20. Schumi J, Wittes JT. Through the looking glass: understanding non-inferiority. Trials. 2011;12:106.
  21. Althunian TA, de Boer A, Klungel OH, Insani WN, Groenwold RHH. Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review. Trials. 2017;18(1):107.
  22. Atkinson AJ, Huang SM, Lertora JJL, Markey SP. Principles of Clinical Pharmacology. Amsterdam/Boston: Academic Press; 2012.
  23. European Medicines Agency [Internet]. Guideline on Investigation of Bio - equivalence. CPMP/EWP/QWP/1401/ 98 Rev. 1/ Corr. 2010 Jan 20 [cited 2020 Jan 05]. Available from: https://www.ema. europa.eu/en/ documents/scientificguideline/ guideline-investigationbioequivalence- rev1_en.pdf.
  24. Nardini C. The ethics of clinical trials. Ecancermedicalscience. 2014;8:387.
  25. Ayling K, Brierley S, Johnson B, Heller S, Eiser C. How standard is standard care? Exploring control group outcomes in behaviour change interventions for young people with type 1 diabetes. Psychol Health. 2015;30(1):85–103.
  26. Jensen JS, Bielefeldt AØ, Hróbjartsson A. Active placebo control groups of pharma - cological interventions were rarely used but merited serious consideration: a methodo - logical overview. J Clin Epidemiol. 2017;87:35–46.

Search

Articles

Editorial
EMWA News
President's Message
Medical illustration in the 21st century and beyond
Visualisations in science communication: Friend or foe?
How and why it works: The principles and history behind visual communication
Get your (visual) act together: Optimising the design of labels and arrows in medical illustrations
A picture is worth a thousand words
The evolution of the scientific poster: From eye-sore to eye-catcher
Leveraging infographics in study schemas
Enhancing accessibility of study data: The development of a graphical abstract for lay summaries of clinical trial results
Connecting medical writers in Portugal through visual communication
Clinical trial design: Considerations for medical writers developing clinical trial protocols
Planting a “non-biological” seed – will this meme persist?
Regulatory Matters
News from the EMA
Journal Watch
Getting Your Foot in the Door
Veterinary Medical Writing
Good Writing Practice
Medical Writing Humour
Out on our Own

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief:

Co-Editor:

Managing Editor

show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: